ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,694,000 | -9.1% | 940,000 | 0.0% | 1.42% | -17.0% |
| Q3 2016 | $12,869,000 | +62.0% | 940,000 | -12.6% | 1.71% | +62.1% |
| Q2 2016 | $7,944,000 | +15.7% | 1,075,000 | 0.0% | 1.06% | +9.3% |
| Q1 2016 | $6,869,000 | +34.0% | 1,075,000 | +31.1% | 0.96% | +52.7% |
| Q4 2015 | $5,125,000 | +22.5% | 820,000 | +14.4% | 0.63% | +1.1% |
| Q3 2015 | $4,184,000 | -8.0% | 716,500 | +30.3% | 0.62% | +4.5% |
| Q2 2015 | $4,549,000 | +0.4% | 550,000 | 0.0% | 0.60% | -0.3% |
| Q1 2015 | $4,532,000 | – | 550,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,000,000 | $96,720,000 | 33.30% |
| Opaleye Management Inc. | 1,670,000 | $13,460,000 | 9.94% |
| Slate Path Capital LP | 6,620,000 | $53,357,000 | 4.04% |
| Granite Point Capital Management, L.P. | 648,000 | $5,223,000 | 3.74% |
| Palo Alto Investors LP | 6,917,248 | $55,754,000 | 2.30% |
| Camber Capital Management LP | 3,000,000 | $24,180,000 | 1.90% |
| Geduld E E | 277,600 | $2,237,000 | 1.21% |
| Elk Creek Partners, LLC | 290,886 | $2,345,000 | 1.01% |
| SELZ CAPITAL LLC | 400,000 | $3,224,000 | 0.81% |
| GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $9,672,000 | 0.81% |